Vireo Growth Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
British Columbia, Canada
Business Address
207 SOUTH 9TH STREET, MINNEAPOLIS, MN, 55402
Mailing Address
207 SOUTH 9TH STREET, MINNEAPOLIS, MN, 55402
Phone
604-617-5421
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 17, 2026 | View on SEC |
| 10-K Annual financial report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 8-K Current report of material events | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
Material Events
8-K
Acquisition
March 25, 2026
High Impact
- Acquisition of 45 cannabis stores and 2 manufacturing facilities via credit bid
- 140% increase in total store count
8-K
Acquisition
December 22, 2025
High Impact
- Vireo Growth Inc., through its subsidiary, is acquiring cannabis dispensary assets in Colorado from PharmaCann Inc.
- The acquisition is valued at approximately $49 million, primarily paid with Vireo's company shares, and includes taking on some of PharmaCann's related debts.
8-K
Acquisition
December 10, 2025
High Impact
- Vireo Growth Inc., through its subsidiary, acquired a majority of Medicine Man Technologies, Inc. (Schwazze) assets.
- The acquisition was executed via a 'credit bid' using approximately $111 million of Schwazze's Senior Secured Convertible Notes during its restructuring process.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.